Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

Novel drug delivery approach that utilizes long-acting injectable microcrystals may enable new options for long-term delivery ...

Researchers suggest discoveries may lead to new strategies for treating skin diseases, inflammation, diabetes, and ...

Why didn’t analysts share the same fear that gripped investors about Sarepta stock? One reason is the known risk of acute liver injury associated with adeno-associated virus vector (AAV)-based gene ...

Cellares’ Cell Shuttle performed all unit operations in an automated manner, including cell isolation, enrichment, gene ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Scientists suggest study findings could point to the future development of new treatments for age-related cognitive decline.

New research suggests that VREfm have the ability to produce bacteriocin, an antimicrobial that can kill or inhibit other ...

Research lead Sven-Erik Behrens, PhD, at the Institute of Biochemistry and Biotechnology at MLU, and colleagues, reported ...

The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure ...

By replacing the defective gene associated with Dravet syndrome in mice, scientists successfully alleviated symptoms without side effects.

In a new study, results suggest that in a preclinical model, two FDA-approved flu antivirals did not successfully treat ...